{"id":"W2916772411","doi":"10.1210/jc.2018-02335","title":"Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Alkaline Phosphatase Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"University of California, San Francisco; Swedish Orphan Biovitrum; Ultragenyx Pharmaceutical; National Institutes of Health; Centre Hospitalier Universitaire de Toulouse; Cincinnati Children's Hospital Medical Center; Sanofi; National Center for Advancing Translational Sciences; Wellcome Trust; Alexion Pharmaceuticals; King Faisal Specialist Hospital and Research Centre; Pfizer; Mayo Clinic","keywords":"Hypophosphatasia; Open label; Medicine; Pediatrics; Pharmacology; Adverse effect; Alkaline phosphatase; Chemistry; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002060618,0.000812789,0.001484729,0.000268833,0.0002335459,0.0004777944,0.0005239967,0.0008905987,0.001595645],"category_scores_gemma":[0.001254114,0.0003417605,0.0008664899,0.0002704268,0.0006955999,0.0005433278,0.0002246221,0.001681609,0.0002968858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005411377,"about_ca_system_score_gemma":0.001099592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004355785,"about_ca_topic_score_gemma":0.001086576,"domain_scores_codex":[0.9993511,0.0004110884,0.00004192162,0.00005081261,0.00007992025,0.00006511837],"domain_scores_gemma":[0.998949,0.000302581,0.0003577626,0.00006938984,0.00007573765,0.0002455609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7446108,0.08054282,0.0197815,0.002289658,0.001433877,0.0007625009,0.000572539,0.001429253,0.04002076,0.0001874416,0.001655535,0.1067132],"study_design_scores_gemma":[0.3393214,0.6306373,0.02370888,0.00007868619,0.0003176608,0.0005919575,0.0001187095,0.0005468494,0.003002282,0.00005912908,0.001597154,0.00001993241],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964021,0.001832307,0.0002852577,0.0001052679,0.0000320301,0.000900457,0.0002054862,0.00002162886,0.000215324],"genre_scores_gemma":[0.9919918,0.002830412,0.0016269,0.0003029271,0.0001337904,0.002134834,0.0005224157,0.000009488711,0.0004474347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002060618,"threshold_uncertainty_score":0.01089776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06258034460161602,"score_gpt":0.4427943887113617,"score_spread":0.3802140441097457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}